Where it comes from
- Made in
- POMC neurons of the hypothalamus, and the skin
- Sent out by
- With the other POMC products
- Acts on
- Hypothalamic MC4R neurons
- Melanocytes
What it does
- Suppresses appetite through MC4R, and may be the main natural ligand for that receptor in the human hypothalamus 1
- A POMC variant, Tyr221Cys, weakens its binding to MC4R and ran with obesity in the families carrying it 1
- Its pigmentary effects are secondary to alpha-MSH, which binds MC1R far more strongly
In medicine
- None of its own; the MC4R medicines, setmelanotide among them, act on the receptor it shares with alpha-MSH
- It is measured only in research, and antibodies raised against it cross-react with the other melanocortins, so a reported level is hard to read 2
Beyond the body’s own use
- There is no beta-MSH product and no trial of one; what is asked of it is whether it, rather than alpha-MSH, sets appetite in people
- That question exists because human POMC is cut into beta-MSH and the mouse’s is not, so the mouse work that built melanocortin pharmacology could not test it 1
- The evidence for a human role is the Tyr221Cys variant and the family studies around it, which is thin ground for a receptor as important as MC4R 1
- Whether beta-MSH reaches the brain from the blood is unknown, and any attempt at a medicine would have to answer that first
Sources
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.